The final model included age, sex, BMI, prior venous thromboembolism, digoxin prescription, HbA1c, ALT, creatinine, haemoglobin, platelet count, and the presence of the following symptoms within 6 months prior to the prediction date: abdominal pain, weight loss, jaundice, heartburn, indigestion and nausea. This evidence concerns the gene GPT and venous thromboembolism.